The following details were available for trading and market data about the stock of Prestige Brand as of writing:
Trading Details of Prestige Brand (PBH)
Current Share Price:
$68.14
Previous Year's Closing Price:
$61.22
Percentage Price Change (YTD):
11.3%
Market Cap:
$3.38 billion
52-week Price Range:
$52.9 - $75.31
Dividend Per Share:
$0
EPS (TTM):
-1.61
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
14.72
Company Profile and Business Description for Prestige Brand
Prestige Brands Holdings, Inc., incorporated on June 24, 2004, is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, and club, convenience, and dollar stores in North America (the United...to see full details, pleaseLogin / Register to view.
ETFs Holding Prestige Brand Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Prestige Brand stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Prestige Brand stock holding. There are a total of 52 ETFs in Fknol.com records which are holding Prestige Brand stock in their portfolio. See Full List.
AVUS is an actively managed diverse portfolio of U.S. large-, mid-, and small-cap stocks aiming to find those with lower price relative to valuations. ...Full Details
The WisdomTree U.S. SmallCap Earnings Fund tracks an index of US small-cap stocks weighted by firms' earnings from core operations. The index is a small-cap subset of the WisdomTree Earnings Index. ...Full Details
The Vanguard ESG U.S. Stock ETF tracks a market-cap-weighted index of US companies screened for environmental, social, and corporate governance (ESG) criteria. ...Full Details
The Franklin LibertyQ U.S. Small-Cap Equity ETF tracks a multi-factor US small-cap index based on a composite scores of quality, value, momentum, and low-volatility. ...Full Details
The Schwab Fundamental US Small Company Index ETF tracks a fundamentally selected and weighted Russell index of small firms based on adjusted sales, retained operation cash flow, and dividends plus buybacks. ...Full Details
The Schwab Fundamental U.S. Broad Market Index ETF tracks a fundamentally selected and weighted Russell Index based on sales, cash flow and dividends/buybacks. ...Full Details
See Full List of ETFs holding Prestige Brand stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Major Pharmaceuticals Sector
Along with Prestige Brand Holdings, Inc., the following other peer (competitor) companies also exist within the same Major Pharmaceuticals - Healthcare sector whose company profile and dividend history is as follows:
▶ Abbott Labs (ABT): Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ....See Detailed Company Profile, Dividend History and Recent Candlestick Patterns.
▶ AbbVie (ABBV): AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile, Dividend History and Recent Candlestick Patterns.
▶ Abeona Therapeutics (ABEO): Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile, Dividend History
▶ AC Immune SA (ACIU): AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile, Dividend History
▶ ACADIA Pharma (ACAD): ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile, Dividend History
▶ Acasti Pharma (ACST): Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile, Dividend History
▶ AcelRx Pharma (ACRX): AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile, Dividend History
▶ Achillion Pharma (ACHN): Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ....See Detailed Company Profile, Dividend History
▶ Aclaris Therapeutics (ACRS): Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile, Dividend History
▶ Actinium Pharma (ATNM): Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile, Dividend History
▶ Acura Pharma (ACUR): Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile, Dividend History
▶ Adamas Pharma (ADMS): Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile, Dividend History
▶ Adamis Pharma (ADMP): Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile, Dividend History
▶ Aduro Biotech (ADRO): Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile, Dividend History
▶ Advaxis (ADXS): Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile, Dividend History
▶ Aeglea BioTherapeutics (AGLE): Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile, Dividend History
▶ AEterna Zentaris (AEZS): Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ....See Detailed Company Profile, Dividend History
▶ Affimed (AFMD): Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ....See Detailed Company Profile, Dividend History
▶ Agile Therapeutics (AGRX): Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ....See Detailed Company Profile, Dividend History
▶ Agios Pharma (AGIO): Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ....See Detailed Company Profile, Dividend History